|
Transcription factors | Abbreviation of transcription factors | Function in Tfh cell differentiation | Signaling pathways | Related diseases |
|
B-cell lymphoma 6 protein | Bcl6 | Initiates the differentiation of Tfh cells at the early stage of Tfh cell generation | Be induced by IL-6-STAT1/STAT3 signaling, inhibits the IL-7R/STAT5 axis, suppresses microRNAs (miR-17-92 and miR-31), a direct target of ATF-3 | Acute lymphocytic choriomeningitis virus (LCMV) infection [11] |
Chronic immune thrombocytopenia (cITP) [12] |
Systemic lupus erythematosus (SLE) [13] |
IgG4-related disease (IgG4-RD) [14] |
Rheumatoid arthritis (RA) [15] |
B lymphocyte maturation protein 1 | Blimp-1 | Inhibits the differentiation of Tfh cells | Inhibits the expression of Bcl6 | IgG4-RD [14] |
Activating transcription factor 3 | ATF-3 | Initiates the differentiation of Tfh cells | Targets Bcl6 in CD4+T cells | Colitis [16] |
c-Musculoaponeurotic-fibrosarcoma | c-Maf | Promotes the differentiation of Tfh cells | c-Maf and Bcl6 synergistically orchestrate genes that define core characteristics of Tfh cell biology | cITP [12] |
Basic leucine zipper transcription factor | Batf | Promotes the differentiation of Tfh cells | Regulates the expression of Bcl6 and c-Maf, cooperates with IRF4 during the development of Tfh cells, be regulated by IL-4-STAT6 and IL-6-STAT3 signaling | IgG4-RD [17] |
Interferon regulatory factor 4 | IRF4 | Promotes the differentiation of Tfh cells | Regulates the generation of Tfh cells in a Bcl6-dependent manner, regulates the production of IL-21 and controls most IL-21-regulated genes by IL-21-STAT3 axis | LCMV infection [18] |
Interferon regulatory factor 8 | IRF8 | Inhibits the differentiation of Tfh cells | Binds to the promoter region of IRF4 gene and inhibits transcription and transactivation of IRF4 | Inflammatory bowel disease (IBD) [19] |
Signal transducers and activators of transcription 1 | STAT1 | Promotes the differentiation of Tfh cells at the early stage of Tfh cell generation | Regulates the differentiation of Tfh cells by IL-6-STAT1-Bcl6 signaling | Viral infection [20] |
SLE [21, 22] |
Signal transducers and activators of transcription 3 | STAT3 | Promotes the differentiation of Tfh cells | Regulates the expression of Bcl6 | RA [23] |
Signal transducers and activators of transcription 4 | STAT4 | Promotes the differentiation of Tfh cells | STAT4 and T-bet are coexpressed with Bcl6 to coordinate the production of IL-21 and IFN-γ by Tfh cells | Acute LCMV infection [24] |
SLE [22] |
Signal transducers and activators of transcription 5 | STAT5 | Inhibits the differentiation of Tfh cells | Downregulates Bcl6 expression and upregulates Blimp-1 expression through IL-2/IL-7/IL-10-STAT5 signaling | LCMV infection [25, 26] |
T-box expressed in T cells | T-bet | Mildly inhibits the early differentiation of Tfh cells, but promotes Tfh cell proliferation and apoptotic intervention at the late effector phase | T-bet and STAT4 are coexpressed with Bcl6 to coordinate the production of IL-21 and IFN-γ by Tfh cells | LCMV infection [2, 24, 27] |
SLE [22] |
T cell-specific transcription factor 1 | TCF-1 | Promotes the differentiation of Tfh cells at the early stage of Tfh cell generation | Promotes the expression of Bcl6, but represses the expression of Blimp-1 | LCMV infection [7, 28–30] |
Lymphoid enhancer binding factor 1 | LEF-1 | Promotes the differentiation of Tfh cells at the early stage of Tfh cell generation | Works synergistically with TCF-1 to enhance the expression of ICOS and Bcl6 | LCMV infection [30] |
The high-mobility group- (HMG-) box 2 | TOX2 | Initiates the differentiation of Tfh cells | Be regulated by Bcl6 and STAT3 in the initial stage of Tfh cell generation, inhibits IL-2 and/or enhances IL-6 signaling to promote Bcl6 expression | Viral infection [31] |
Achaete-scute homolog 2 | Ascl2 | Promotes the differentiation of Tfh cells | Upregulates CXCR5 but not Bcl6 and downregulates CCR7 expression as well as IL-2 signaling | Sjögren syndrome (SS) [32] |
BTB and CNC homolog 2 | Bach2 | Inhibits the differentiation of Tfh cells | Suppresses the expression of Bcl6 by directly binding to the promoter, negatively regulates CXCR5 expression | Viral infection [33, 34] |
Forkhead-box protein O1 | FOXO1 | Inhibits the differentiation of Tfh cells | Negatively regulates the differentiation of Tfh cells through an ICOS-mTORC2-FOXO1 signaling axis in the early stages of differentiation, negatively regulates the expression of Bcl6 | Angioimmunoblastic T cell lymphoma induced [35] |
Forkhead-box protein P1 | FOXP1 | Inhibits the differentiation of Tfh cells | Negatively regulates the expression of CTLA-4 and IL-21 in activated CD4+T cells | LCMV infection [36] |
Krüppel-like factor 2 | KLF2 | Inhibits the differentiation of Tfh cells | Downregulates S1PR1, induces the expression of Blimp-1, miRNA92a-mediated Tfh precursor induction is regulated by PTEN-PI3K-KLF2 signaling | Type 1 diabetes (T1D) [37] |
LCMV infection [38] |
|